Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a 'mitohormesis' mechanism involving reactive oxygen species and PGC-1.
about
Pleiotropic effects of statinsStatin-Induced Increases in Atrophy Gene Expression Occur Independently of Changes in PGC1α Protein and Mitochondrial ContentStatin-induced Myopathy in Skeletal Muscle: the Role of ExerciseInflammatory Stress Sensitizes the Liver to Atorvastatin-Induced Injury in ApoE-/- MiceHepatic Fgf21 Expression Is Repressed after Simvastatin Treatment in MiceEffects of exercise training on mitochondrial function in patients with type 2 diabetes.Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation.Protective Effects of Quercetin on Mitochondrial Biogenesis in Experimental Traumatic Brain Injury via the Nrf2 Signaling Pathway.Effects of lipid-lowering drugs on irisin in human subjects in vivo and in human skeletal muscle cells ex vivo.A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy.Pressure overload-induced mild cardiac hypertrophy reduces left ventricular transmural differences in mitochondrial respiratory chain activity and increases oxidative stress.Protection of rat skeletal muscle fibers by either L-carnitine or coenzyme Q10 against statins toxicity mediated by mitochondrial reactive oxygen generationMolecular mechanisms of statin intolerancePharmacological Strategies to Retard Cardiovascular AgingSimvastatin impairs exercise training adaptations.Quercetin induces mitochondrial biogenesis in experimental traumatic brain injury via the PGC-1α signaling pathway.Effects of Coenzyme Q10 on Skeletal Muscle Oxidative Metabolism in Statin Users Assessed Using 31P Magnetic Resonance Spectroscopy: a Randomized Controlled StudyModulation of mitochondrial bioenergetics in a skeletal muscle cell line model of mitochondrial toxicity.Intolerance to statins: mechanisms and management.Muscles Susceptibility to Ischemia-Reperfusion Injuries Depends on Fiber Type Specific Antioxidant Level.Skeletal muscle mitochondrial dysfunction during chronic obstructive pulmonary disease: central actor and therapeutic target.Exercise-induced myalgia may limit the cardiovascular benefits of statins.The effects of statin medications on aerobic exercise capacity and training adaptations.Heart failure with preserved ejection fraction: Defining the function of ROS and NO.The role of mitochondria in statin-induced myopathy.Statins, fibrates, thiazolidinediones and resveratrol as adjunctive therapies in sepsis: could mitochondria be a common target?Moderate Exercise Allows for shorter Recovery Time in Critical Limb Ischemia.Iron, Oxidative Damage and Ferroptosis in Rhabdomyosarcoma.Mechanisms of hepatotoxicity associated with the monocyclic β-lactam antibiotic BAL30072.Simvastatin Promotes Cardiac Myocyte Relaxation in Association with Phosphorylation of Troponin I.Chronology of mitochondrial and cellular events during skeletal muscle ischemia-reperfusion.A Novel Danshensu Derivative Prevents Cardiac Dysfunction and Improves the Chemotherapeutic Efficacy of Doxorubicin in Breast Cancer Cells.Role of PGC-1α in Vascular Regulation: Implications for Atherosclerosis.Simvastatin induces mitochondrial dysfunction and increased atrogin-1 expression in H9c2 cardiomyocytes and mice in vivo.Pleiotropic Effects of Statins on the Cardiovascular System.Histopathologic and Biochemical Evidence for Mitochondrial Disease Among 279 Patients with Severe Statin Myopathy.MitoTimer: a novel tool for monitoring mitochondrial turnover.Skeletal muscle ischemia-reperfusion injury and cyclosporine A in the aging rat.Simvastatin offers new prospects for the treatment of Duchenne muscular dystrophy.Statins, Muscle Disease and Mitochondria.
P2860
Q26783220-F278CC2E-3581-459D-86FC-19D421C74379Q27305332-BED877E3-1F48-4A2C-BB26-39CEEB74F4B9Q28086884-D95D7BDB-80CE-4A6C-9201-1FA23C19A89CQ28552676-612CAE7F-1533-47F1-8342-600A600A2828Q28553822-E9EC3E1F-D98F-479F-B658-AA7FA123C9DBQ34023559-7B33E2D0-0127-44DF-A8DC-34020D92411BQ34635121-9F5A3238-8888-41BB-B063-014EF6FF80C2Q34679432-D5A5A217-F077-468C-ADB9-E30013B413BBQ34984106-4F2992E9-D422-46CC-AA8D-E217A8F9A76FQ36179162-C9C1396B-94EB-47E4-9417-226D3BE4E61BQ36193631-419559FD-97B8-4050-8F98-C84F25B8EE28Q36844636-4BB16074-5333-49FD-9C31-F4D960D3AB97Q36958324-B1C0AB3C-BC12-4B12-A143-71FFB49454B4Q36972415-98B96463-239E-4A25-B99F-A1482918E4F5Q37100826-6D838B29-BE4B-4052-9A2B-8938BCB82793Q37228027-F69CBC0B-15D1-4F5D-9AE5-4897C48A74EFQ37234510-FBB7EBB1-D0FA-4B8D-8AF6-AFCDFD7C7B92Q37541019-D938A08A-EF74-4D40-8C9C-F03CC41E3C92Q37577161-F9F1AC83-13CA-4C5B-86BF-334391C07A53Q37625350-7612CA6F-876C-4225-A8BE-0C48A84CCF74Q38078795-822903F5-708C-4582-BCB8-A742488F10AEQ38128190-3649FFA7-7F6F-40B3-9CB3-D308840F2106Q38228143-E4014B2F-8F1D-4A67-A649-35907EB24394Q38482322-914886BE-6BCB-44CA-AC23-AFC1254B4E24Q38492567-0D56A739-F92E-4FD5-9942-D69602776CCEQ38565307-87E52CBA-89C8-4649-9DCC-DCA2815B6321Q38633070-02CC1730-DA30-49AE-886F-D72551E1D8BFQ38637192-1B969A5C-3C15-490E-9AF2-BC02C906D7FAQ38702441-AD1E8CD9-4247-4994-B57A-CBB66687F735Q38806114-314D4E2C-7006-418B-8849-848C114F9DAEQ38807921-99737B73-F076-4E88-9FEA-CFBCB5594073Q38865730-1E1E8E40-E6F8-44CA-92A9-CB2FC4E41175Q38867606-89FFDF8C-2D46-475E-B85D-47048D546DB4Q38949342-E97953E1-15AA-442E-BCFF-E1C0D77D5F34Q39069187-56C3135D-B02E-43BE-97C6-538DFEF1D5DEQ39166726-88D97606-18F9-409A-9ED7-71720F97F2C5Q39802032-09FCBBAD-9A62-4688-8649-56D4BA2FA292Q40085982-F7499157-DAE9-4C6A-A1FC-7331695CC558Q40401831-679268AE-9990-49D0-883D-36A9B385B4B4Q41552418-18C6E5B8-AE5D-482E-A29F-D920D233B1E6
P2860
Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a 'mitohormesis' mechanism involving reactive oxygen species and PGC-1.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Opposite effects of statins on ...... tive oxygen species and PGC-1.
@ast
Opposite effects of statins on ...... tive oxygen species and PGC-1.
@en
type
label
Opposite effects of statins on ...... tive oxygen species and PGC-1.
@ast
Opposite effects of statins on ...... tive oxygen species and PGC-1.
@en
prefLabel
Opposite effects of statins on ...... tive oxygen species and PGC-1.
@ast
Opposite effects of statins on ...... tive oxygen species and PGC-1.
@en
P2093
P2860
P356
P1476
Opposite effects of statins on ...... tive oxygen species and PGC-1.
@en
P2093
Andoni Echaniz-Laguna
Anne-Laure Charles
Bernard Geny
François Piquard
Frédéric Daussin
Jamal Bouitbir
Joffrey Zoll
Michel Kindo
P2860
P304
P356
10.1093/EURHEARTJ/EHR224
P50
P577
2011-07-20T00:00:00Z